+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Startup Series - Unicorn Quest: Innovators in Medical and Pharma

  • PDF Icon

    Report

  • 47 Pages
  • January 2025
  • Region: Global
  • GlobalData
  • ID: 6049434
The Startup Series report, "Unicorn Quest - Innovators in Medical and Pharma," highlights startups poised to become unicorns in the medical and pharma sectors. It explores how advancements such as AI-driven diagnostics, gene editing, synthetic biology, and personalized healthcare solutions help address unmet medical needs and enhance precision medicine. The report provides insights into startups' growth potential, innovation strategies, and impact, enabling stakeholders to identify promising companies and understand their contributions to the evolving medical and pharmaceutical landscapes.

Amidst global efforts to revolutionize healthcare, startups in the medical and pharma sectors are driving transformative innovations. They are developing cutting-edge solutions in diagnostics, therapeutics, and biotechnology, including AI-powered tools, gene editing, and digital health platforms. The report Startup Series - Unicorn Quest: Innovators in Medical and Pharma highlights key startups driving healthcare innovation and disruption. Utilizing insights from the analyst’s Disruptor Intelligence Center and expert analysis, the report provides stakeholders with a comprehensive overview of emerging trends, startup investors, and investment opportunities.

Scope

  • The startups featured in this report were founded in 2015 or later and provide innovative solutions in the medical and pharmaceutical sectors. Their offerings span across diagnostics, monitoring, gene editing, synthetic biology, therapeutic development, AI-driven tools, and more. Startups are leveraging technology to address critical healthcare challenges through non-invasive diagnostics, advanced gene-editing platforms, and personalized medicine.

Reasons to Buy

  • Stay updated: Gain insights into the latest advancements and potential unicorns in the medical and pharma sectors.
  • Discover new startups: The report highlights promising startups pioneering disruptive technologies in diagnostics, therapeutics, and digital tools.
  • Identify key focus areas: Understand innovation trends such as AI-driven diagnostics, gene editing, and synthetic biology, and the startups excelling in these domains.
  • Learn about innovation areas: Deep-dive into pharma and medical startups researching cutting-edge technologies to offer distinct solutions.
  • Assess investment potential: Access valuable information for assessing the investment potential of different startups.

Table of Contents

1. Methodology

2. Scope of the report

3. Executive summary

4. Startup map

5. Venture financing trend

6. Sector analysis: Startups - Medical and Pharma

7. Appendix: Definitions

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Activ Surgical
  • Altamira Therapeutics
  • Antheia
  • Asimov
  • BioIntellisense
  • Closed Loop Medicine
  • ConcertAI
  • CorVista Health
  • Dewpoint Therapeutics
  • DNA Script SAS
  • Excision BioTherapeutics
  • eXo Imaging
  • Henlius
  • Hummingbird Bioscience
  • Karius
  • knowRX
  • MD Anderson
  • MedRhythms
  • Mission Bio
  • Mission Therapeutics
  • Mitsubishi Tanabe Pharma Corporation
  • MOBILion Systems
  • Nanite
  • Novo Nordisk
  • Obsidian Therapeutics
  • Palleon Pharmaceuticals
  • RevOpsis Therapeutics
  • Saliogen Therapeutics
  • SeLux Diagnostics
  • Serum Institute of India
  • SiPhox
  • Skyhawk Therapeutics
  • Synthekine
  • Tissium SA
  • TMRW Life Sciences
  • Truvian Sciences
  • Univercells
  • University of Miami
  • Valo Health
  • Visby Medical
  • Xilis